Procalcitonin in the diagnosis of inflammation in intensive care units

被引:27
作者
Dorizzi, Romolo M.
Polati, Enrico
Sette, Piersandro
Ferrari, Anna
Rizzotti, Paolo
Luzzani, Aldo
机构
[1] Osped Civile, Lab Anal Chim Clin & Ematol, Azienda Osped Verona, I-37126 Verona, Italy
[2] A Osped Civile Maggiore, Unita Operat Anesthesia & Rianimaz, Azienda Osped Verona, I-37126 Verona, Italy
关键词
procalcitonin (PCT); likelihood ratio; SIRS; infection; sepsis; septic shock; cutoff value;
D O I
10.1016/j.clinbiochem.2006.08.011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To assess the effectiveness of different procalcitonin cutoff values to distinguish non-infected (negative+STRS) from infected (sepsis+severe sepsis+septic shock) medical and surgical patients. Design and methods: PCT plasma concentration was measured using an automated chemiluminescence analyzer in 10 13 samples collected in 103 patients within 24 h of admission in ICU and daily during the ICU stay. We compared PCT levels in medical and surgical patients. We also compared PCT plasma levels in non-infected versus infected patients and in SIRS versus infected patients both in medical and in surgical groups. Results: Median values of PCT plasma concentrations were significantly higher in infected than in non-infected groups, both in medical (3.18 vs. 0.45 mu g/L) (p < 0.0001) and in surgical (10.45 vs. 3.89 mu g/L; p < 0.0001) patients. At the cutoff of 1 mu g/L, the LR+ was 4.78, at the cutoff of 6 mu g/L was 12.53, and at the cutoff of 10 mu g/L was 18.4. Conclusions: This study highlights the need of different PCT cutoff values in medical and surgical critically ill patients, not only at the ICU admission but also in the entire ICU stay. (c) 2006 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:1138 / 1143
页数:6
相关论文
共 42 条
[1]   Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients [J].
Aouifi, A ;
Piriou, V ;
Bastien, O ;
Blanc, P ;
Bouvier, H ;
Evans, R ;
Célard, M ;
Vandenesch, F ;
Rousson, R ;
Lehot, JJ .
CRITICAL CARE MEDICINE, 2000, 28 (09) :3171-3176
[2]   Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit [J].
Balci, C ;
Sungurtekin, H ;
Gürses, E ;
Sungurtekin, U ;
Kaptanoglu, B .
CRITICAL CARE, 2003, 7 (01) :85-90
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin [J].
Brunkhorst, FM ;
Eberhard, OK ;
Brunkhorst, R .
CRITICAL CARE MEDICINE, 1999, 27 (10) :2172-2176
[5]  
Brunkhorst FM, 2000, INTENS CARE MED, V26, pS148, DOI 10.1007/BF02900728
[6]   Toward resolving the challenges of sepsis diagnosis [J].
Carrigan, SD ;
Scott, G ;
Tabrizian, M .
CLINICAL CHEMISTRY, 2004, 50 (08) :1301-1314
[7]  
Castelli GP, 2006, MINERVA ANESTESIOL, V72, P69
[8]   Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction [J].
Castelli, GP ;
Pognani, C ;
Meisner, M ;
Stuani, A ;
Bellomi, D ;
Sgarbi, L .
CRITICAL CARE, 2004, 8 (04) :R234-R242
[9]  
Chan-Yeung M, 2004, INT J TUBERC LUNG D, V8, P2
[10]   Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].
Christ-Crain, M ;
Jaccard-Stolz, D ;
Bingisser, R ;
Gencay, MM ;
Huber, PR ;
Tamm, M ;
Müller, B .
LANCET, 2004, 363 (9409) :600-607